UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041065
Receipt number R000046901
Scientific Title A survey on the lifestyle changes of patients with diabetes under the state of emergency
Date of disclosure of the study information 2020/07/10
Last modified on 2021/05/10 10:45:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A survey on the lifestyle changes of patients with diabetes under the state of emergency

Acronym

A survey on the lifestyle changes of patients with diabetes under the state of emergency

Scientific Title

A survey on the lifestyle changes of patients with diabetes under the state of emergency

Scientific Title:Acronym

A survey on the lifestyle changes of patients with diabetes under the state of emergency

Region

Japan


Condition

Condition

Diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the management status of the blood sugar level and weight of the patients with diabetes under the state of emergency due to the COVID-19 epidemic.

Basic objectives2

Others

Basic objectives -Others

epidemiologic study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in HbA1c before and after the state of emergency

Key secondary outcomes

Change in weight before and after the state of emergency.
Each answer to the questionnaire.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The survey targets are those who meet all of the following criteria;
1. Patients who visit "Berry Clinic" or "Tomonaga Clinic" regularly.
2. Any patients regardless of their gender and age
3. Patients with diabetes.
4. Patients who consent to participate in the survey.

Key exclusion criteria

N/A

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Mio
Middle name
Last name Masuda

Organization

Berry Clinic

Division name

N/A

Zip code

272-0143

Address

Cradea M&S 1F, 4-14-10 Ainokawa, Ichikawa City, Chiba

TEL

047-358-6318

Email

berryclinic@icloud.com


Public contact

Name of contact person

1st name Mio
Middle name
Last name Masuda

Organization

Berry Clinic

Division name

N/A

Zip code

272-0143

Address

Cradea M&S 1F, 4-14-10 Ainokawa, Ichikawa City, Chiba

TEL

047-358-6318

Homepage URL


Email

berryclinic@icloud.com


Sponsor or person

Institute

Berry Clinic

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

The Diabetes and lifestyle Center, Tomonaga Clinic

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The ethics committee at the Diabetes and lifestyle Center, Tomonaga Clinic

Address

Shinyon curumu building 9F, 4-2-23, Shinjuku, Shinjuku-ku, Tokyo, Japan

Tel

03-3351-0032

Email

info@tomonaga-clinic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

ベリークリニック/Berry Clinic、ともながクリニック 糖尿病・生活習慣病センター/The Diabetes and lifestyle Center, Tomonaga Clinic


Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 10 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://link.springer.com/article/10.1007/s13340-021-00505-6

Number of participants that the trial has enrolled

1000

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results

2021 Year 04 Month 20 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 06 Month 15 Day

Date of IRB

2020 Year 07 Month 10 Day

Anticipated trial start date

2020 Year 07 Month 10 Day

Last follow-up date

2020 Year 09 Month 23 Day

Date of closure to data entry

2020 Year 09 Month 28 Day

Date trial data considered complete

2020 Year 10 Month 13 Day

Date analysis concluded

2020 Year 11 Month 30 Day


Other

Other related information

Observational Study


Management information

Registered date

2020 Year 07 Month 10 Day

Last modified on

2021 Year 05 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046901


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name